33 related articles for article (PubMed ID: 29309983)
1. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
Zhu P; Pichardo-Rojas PS; Dono A; Tandon N; Hadjipanayis CG; Berger MS; Esquenazi Y
J Neurooncol; 2024 May; 168(1):77-89. PubMed ID: 38492191
[TBL] [Abstract][Full Text] [Related]
2. Supratotal Resection: An Emerging Concept of Glioblastoma Multiforme Surgery-Systematic Review And Meta-Analysis.
Aziz PA; Memon SF; Hussain M; Memon AR; Abbas K; Qazi SU; Memon RAR; Qambrani KA; Taj O; Ghazanfar S; Ellahi A; Ahmed M
World Neurosurg; 2023 Nov; 179():e46-e55. PubMed ID: 37451363
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.
Chandra A; Lopez-Rivera V; Ryba B; Chandran AS; Brandel MG; Dono A; Sheinberg DL; Esquenazi YL; Aghi MK
Clin Neurol Neurosurg; 2024 Jan; 236():108084. PubMed ID: 38141552
[TBL] [Abstract][Full Text] [Related]
4. Incidence and relative survival of anaplastic astrocytomas.
Smoll NR; Hamilton B
Neuro Oncol; 2014 Oct; 16(10):1400-7. PubMed ID: 24723565
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients.
Gull HH; Von Riegen AC; Beckmann GT; Ketelauri P; Walbrodt S; Santos AN; Oster C; Schmidt T; Glas M; Jabbarli R; Özkan N; Dammann P; Scheffler B; Sure U; Ahmadipour Y
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539563
[TBL] [Abstract][Full Text] [Related]
6. Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma.
Chen XY; Pan DL; Xu JH; Chen Y; Xu WF; Chen JY; Wu ZY; Lin YX; You HH; Ding CY; Kang DZ
Front Oncol; 2021; 11():754920. PubMed ID: 35155182
[TBL] [Abstract][Full Text] [Related]
7. Sex-Specific Differences in Primary CNS Lymphoma.
Roetzer T; Furtner J; Gesperger J; Seebrecht L; Bandke D; Brada M; Brandner-Kokalj T; Grams A; Haybaeck J; Kitzwoegerer M; Leber SL; Marhold F; Moser P; Sherif C; Trenkler J; Unterluggauer J; Weis S; Wuertz F; Hainfellner JA; Langs G; Nenning KH; Woehrer A
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560244
[TBL] [Abstract][Full Text] [Related]
8. Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.
Bartek J; Alattar AA; Dhawan S; Ma J; Koga T; Nakaji P; Dusenbery KE; Chen CC
J Neurooncol; 2019 Oct; 145(1):75-83. PubMed ID: 31471790
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
10. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Brown TJ; Brennan MC; Li M; Church EW; Brandmeir NJ; Rakszawski KL; Patel AS; Rizk EB; Suki D; Sawaya R; Glantz M
JAMA Oncol; 2016 Nov; 2(11):1460-1469. PubMed ID: 27310651
[TBL] [Abstract][Full Text] [Related]
11. Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection.
Carroll KT; Bryant AK; Hirshman B; Alattar AA; Joshi R; Gabel B; Carter BS; Harismendy O; Vaida F; Chen CC
World Neurosurg; 2018 Mar; 111():e790-e798. PubMed ID: 29309983
[TBL] [Abstract][Full Text] [Related]
12. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
[TBL] [Abstract][Full Text] [Related]
13. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
Alattar AA; Carroll KT; Bryant AK; Hirshman B; Joshi R; Carter BS; Harismendy O; Chen CC
World Neurosurg; 2019 Jan; 121():e411-e418. PubMed ID: 30266697
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
